UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of the comprehensive analysis of pollution of the Kacha river by oil products in the information and analytical system

Journal of physics. Conference series, 2021-11, Vol.2094 (5), p.52003

2021

Volltextzugriff (PDF)

Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes

Biochemical and biophysical research communications, 1991-03, Vol.175 (2), p.556-561

1991

Volltextzugriff (PDF)

Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist

The Journal of pharmacology and experimental therapeutics, 1995-12, Vol.275 (3), p.1518

1995

Volltextzugriff (PDF)

A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066

The Journal of pharmacology and experimental therapeutics, 1988-04, Vol.245 (1), p.32

1988

Volltextzugriff (PDF)

Identification of an orally active, nonpeptidyl oxytocin antagonist

The Journal of pharmacology and experimental therapeutics, 1993-01, Vol.264 (1), p.308

1993

Volltextzugriff (PDF)

Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (9), p.1311-1316

1999

Volltextzugriff (PDF)

Nonpeptide oxytocin antagonists: Potent, orally bioavailable analogs of L-371,257 containing A 1- R-(pyridyl)ethyl ether terminus

Bioorganic & medicinal chemistry letters, 1998-11, Vol.8 (21), p.3081-3086

1998

Volltextzugriff (PDF)

In vitro pharmacological profile of a novel structural class of oxytocin antagonists

The Journal of pharmacology and experimental therapeutics, 1991-01, Vol.256 (1), p.304

1991

Volltextzugriff (PDF)

Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948

The Journal of pharmacology and experimental therapeutics, 1991-03, Vol.256 (3), p.827

1991

Volltextzugriff (PDF)

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1803-1806

2003

Volltextzugriff (PDF)

Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist

Life sciences (1973), 1996-03, Vol.58 (14), p.1149-1157

1996

Volltextzugriff (PDF)

L-368,899, a potent orally active oxytocin antagonist for potential use in preterm labor

Drug development research, 1993-11, Vol.30 (3), p.129-142

1993

Volltextzugriff (PDF)

Bradykinin agonist activity of a novel, potent oxytocin antagonist

European journal of pharmacology, 1991-04, Vol.196 (3), p.233-237

1991

Volltextzugriff (PDF)

STUDY OF THE CHEMICAL COMPOSITION OF CONES AND SEEDS OF CONIFEROUS SPECIES OF SIBERIA

Хвойные бореальной зоны, 2023, Vol.41 (1), p.95-100

2023

Volltextzugriff (PDF)

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin

The Journal of pharmacology and experimental therapeutics, 2002-01, Vol.300 (1), p.305-313

2002

Volltextzugriff (PDF)

Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats

Archives internationales de pharmacodynamie et de thérapie, 1985-02, Vol.273 (2), p.251

1985

Volltextzugriff (PDF)

Development of browser game for student’s vocational guidance

Educational resources and technology, 2016, p.25-29

2016

Volltextzugriff (PDF)

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Journal of medicinal chemistry, 1998-06, Vol.41 (12), p.2146-2163

1998

Volltextzugriff (PDF)

Benzodiazepines as Potent and Selective Bradykinin B 1 Antagonists

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1803-1806

2003

Volltextzugriff (PDF)

1-{1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4H-3,1-benzoxazin-2(1H)-one (L-371,257) : a new, orally bioavailable, non-peptide oxytocin antagonist

Journal of medicinal chemistry, 1995-11, Vol.38 (23), p.4634-4636

1995

Volltextzugriff (PDF)

Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery

Archives internationales de pharmacodynamie et de thérapie, 1986-11, Vol.284 (1), p.72

1986

Volltextzugriff (PDF)

Development of orally active oxytocin antagonists : Studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzo yl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

Journal of medicinal chemistry, 1998, Vol.41 (12), p.2146-2163

1998

Volltextzugriff (PDF)

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

Journal of medicinal chemistry, 1995-11, Vol.38 (23), p.4634-4636

1995

Volltextzugriff (PDF)

Progress in the development of oxytocin antagonists for use in preterm labor

Advances in experimental medicine and biology, 1995, Vol.395, p.601

1995

Volltextzugriff (PDF)

ChemInform Abstract: 1-(1-(4-((N-Acetyl-4-piperidinyl)oxy)-2-methoxybenzoyl)piperidin-4-yl)- 4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Oxytocin Antagonist

ChemInform, 1996-03, Vol.27 (11), p.no-no

1996

Volltextzugriff (PDF)

1 – 25 von 402

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(367)
Mit Volltextzugriff
(351)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Application of the comprehensive analysis of pollution of the Kacha river by oil products in the information and analytical system

Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes

Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist

A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066

Identification of an orally active, nonpeptidyl oxytocin antagonist

Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency

Nonpeptide oxytocin antagonists: Potent, orally bioavailable analogs of L-371,257 containing A 1- R-(pyridyl)ethyl ether terminus

In vitro pharmacological profile of a novel structural class of oxytocin antagonists

Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist

L-368,899, a potent orally active oxytocin antagonist for potential use in preterm labor

Bradykinin agonist activity of a novel, potent oxytocin antagonist

STUDY OF THE CHEMICAL COMPOSITION OF CONES AND SEEDS OF CONIFEROUS SPECIES OF SIBERIA

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin

Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats

Development of browser game for student’s vocational guidance

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Benzodiazepines as Potent and Selective Bradykinin B 1 Antagonists

1-{1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4H-3,1-benzoxazin-2(1H)-one (L-371,257) : a new, orally bioavailable, non-peptide oxytocin antagonist

Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery

Development of orally active oxytocin antagonists : Studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzo yl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

Progress in the development of oxytocin antagonists for use in preterm labor

ChemInform Abstract: 1-(1-(4-((N-Acetyl-4-piperidinyl)oxy)-2-methoxybenzoyl)piperidin-4-yl)- 4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Oxytocin Antagonist

Suchergebnisse filtern